Beyond Darwin's Wildest Dreams

Premium

Thanks to genomics technology, evolutionary biologists have been able to ask and answer questions the likes of which Charles Darwin would probably never have imagined. But there is still much to be done, both with all the new data coming on long-studied models as well as often overlooked species that were previously strangers to in-depth genetic analysis. David Kingsley, a professor of developmental biology at Stanford University, is one evolutionary biologist spreading the wealth when it comes to genomics technology.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

Researchers test gene therapy targeting a different cancer protein in a new trial, the New York Times reports.

Pennsylvania State University researchers found that salivary microRNAs could predict which kids would have longer concussion symptoms, according to NPR.

The Associated Press reports Alex Azar, the new Department of Health and Human Services secretary nominee, made millions of dollars as a pharmaceutical executive.

In PNAS this week: immune profiling of breast cancer, transposable element patterns in rice, and more.